The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index, and 1 are not checked yet.
Desferrioxamine shows different potentials for enhancing 5-aminolaevulinic acid-based photodynamic therapy in several cutaneous cell lines
Abstract
Protoporphyrin IX (PpIX) is the photosensitizer in 5-aminolaevulinic acid (ALA)-based photodynamic therapy (PDT). Its further bioconversion to heme requires iron and can be suppressed by iron chelators such as desferrioxamine (DFO). To investigate the effectiveness of DFO in enhancing PpIX-based PDT in skin tissue, we selected fibroblasts, HaCat cells and Hep-2 cells as targets co-cultured with ALA, that have different biological characteristics for PpIX conversion. Evaluated interventions included: (1) blank control (no ALA, no DFO); (2) DFO alone; (3) ALA alone; and (4) DFO in combination with ALA. Before photodynamic irradiation, cellular PpIX level and fluorescence were measured. After irradiation, cell death ratio was calculated and morphological changes in the cells were observed. The results showed that the content and photodynamic effects of cellular PpIX presented in the order Hep-2 cells > HaCat cells > fibroblasts, either co-cultured with ALA alone or with ALA plus DFO. DFO was found to have increasing effects on both PpIX level and cell death ratio in the same order. It was found that DFO had different potentials for augmenting ALA-PDT in these cutaneous cell lines. The cells proliferating more rapidly might be more susceptible to enhancement of DFO.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DFO has been demonstrated to enhance PpIX fluorescence and/or PDT effects in various studies with different cell lines including skin, bladder, and glioblastoma tumor cells [86,87,88,89,90].”
From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [88]
In the citing paper
“Chelator-induced PpIX enhancement is more pronounced at low doses of ALA than at the high doses of ALA that are typically used.”
From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [88]
In the citing paper
“It turns out that the effects of iron chelators on ALA-PpIX fluorescence are highly dependent on the cell line and ALA dose [85,88,92,105].”
From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [88]
Citations
Cites
Guidelines for topical photodynamic therapy: update
Morton, C. A., McKenna, K. E., Rhodes, L. E., & on behalf of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08882.x · Cited by 471
ALA and its clinical impact, from bench to bedside
Krammer, B., & Plaetzer, K. (2008) · Photochemical & Photobiological Sciences · doi:10.1039/b712847a · Cited by 251
Chen, S., Cheng, A.-C., Wang, M.-S., & Peng, X. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2174 · Cited by 167
Aminolevulinic acid: From its unique biological function to its star role in photodynamic therapy
Fukuda, H., Casas, A., & Batlle, A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.04.018 · Cited by 127
de Haas, E. R. M., Kruijt, B., Sterenborg, H. J. C. M., Martino Neumann, H. A., & Robinson, D. J. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700460 · Cited by 118
Pretreatment to Enhance Protoporphyrin IX Accumulation in Photodynamic Therapy
Gerritsen, M., Smits, T., Kleinpenning, M. M., van de Kerkhof, P. C. M., & van Erp, P. E. J. (2008) · Dermatology · doi:10.1159/000183753 · Cited by 118
Cellular Uptake and Release of Two Contrasting Iron Chelators
Cable, H. C., & Lloyd, J. B. (1999) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357991772231 · Cited by 108
Akilov, O. E., Kosaka, S., O’Riordan, K., & Hasan, T. G. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00578.x · Cited by 99
Oleic Acid as Optimizer of the Skin Delivery of 5-Aminolevulinic Acid in Photodynamic Therapy
Pierre, M. B. R., Ricci‐Júnior, E., Tedesco, A. C., & Bentley, M. V. L. B. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-9261-x · Cited by 83
Šmucler, R., & Vlk, M. (2008) · Lasers in Surgery and Medicine · doi:10.1002/lsm.20606 · Cited by 82
Cited by
Current states and future views in photodynamic therapy
Yano, S., Hirohara, S., Obata, M., Hagiya, Y., Ogura, S.-I., Ikeda, A., Kataoka, H., Tanaka, M., & Joh, T. (2011) · Journal of Photochemistry and Photobiology C: Photochemistry Reviews · doi:10.1016/j.jphotochemrev.2011.06.001 · Cited by 540
Yang, X., Palasuberniam, P., Kraus, D., & Chen, B. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025865 · Cited by 158
Hagiya, Y., Endo, Y., Yonemura, Y., Takahashi, K., Ishizuka, M., Abe, F., Tanaka, T., Okura, I., Nakajima, M., Ishikawa, T., et al. (2012) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2011.12.004 · Cited by 129
Zhao, S., Chen, X., Wang, L.-G., Yang, G., Han, D., Teng, L., Yang, M., Wang, D.-Y., Shi, C., Liu, Y.-H., et al. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2201-6 · Cited by 111
Wang, W., Tabu, K., Hagiya, Y., Sugiyama, Y., Kokubu, Y., Murota, Y., Ogura, S., & Taga, T. (2017) · Scientific Reports · doi:10.1038/srep42070 · Cited by 70
Metadata
- Authors
- Yang, J., Xia, Y., Liu, X., Jiang, S., & Xiong, L.
- Affiliations
- Yangtze University (CN)
- Renmin Hospital of Wuhan University (CN)
- Corresponding author
- Xia, Yumin
- Venue
- Lasers in Medical Science
- Published
- 2009-08-25
- Volume
- 25
- Issue
- 2
- Pages
- 251-257
- ISSN
- 0268-8921 (ISSN-L)
- 1435-604X
- OpenAlex
- W2034013141
- Cited by
- 28
- References
- 36
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 2 · 2013: 1 · 2012: 2
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Lasers in Medical Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wuhan University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Porphyrin Metabolism and Disorders
- Health Sciences › Medicine › Dermatology › Nonmelanoma Skin Cancer Studies
- Keywords
- deferoxamine, 5-aminolevulinic acid, photodynamic therapy, protoporphyrin IX, iron chelators, heme biosynthesis, HaCaT keratinocytes, HEp-2 cells, fibroblasts, cell death, skin cancer
- MeSH terms
- Aminolevulinic Acid, Cell Line, Deferoxamine, Drug Synergism, Fibroblasts, Humans, Iron Chelating Agents, Photochemotherapy, Protoporphyrins, Skin Diseases, Cell Death, Photosensitizing Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Desferrioxamine shows different potentials for enhancing 5-aminolaevulinic acid-based photodynamic therapy in several cutaneous cell lines. https://app.cochat.ai/papers/10.1007/s10103-009-0721-0
- The paper
- Yang, J., Xia, Y., Liu, X., Jiang, S., & Xiong, L. (2010). Desferrioxamine shows different potentials for enhancing 5-aminolaevulinic acid-based photodynamic therapy in several cutaneous cell lines. Lasers in Medical Science. https://doi.org/10.1007/s10103-009-0721-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.